Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Clobetasol, PDT, and LLLT for Vulvar Lichen Sclerosus
NCT02416531Completed
- Start
- Jan 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of methylene blue in vulvar lichen sclerosus (LS) (3 arms). Primary endpoint: Change from baseline in biopsies at 1 month. Started Jan 2015; status: completed.
02
Drugs
methylene blue
03
Conditions
vulvar lichen sclerosus (LS)
Beyond the preview
Go deeper on NCT02416531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02416531.